IFT81 and infection: However, lower doses of both anti-DV1 and anti-DV2 serum caused lethal enhancement, showing that serotype-specific as well as serotype-cross-reactive antibodies can also enhance infection in vivo in a dose-dependent manner (Figure 4A and B).